Health Care Roundup: Market Talk
Find insight on Sanofi, ResMed, Lonza and more in the latest Market Talks covering the health care sector.
The Pharma Letter10h
AstraZeneca's Fasenra set to revolutionize COPD treatment
UK pharma major AstraZeneca’s Fasenra (benralizumab), with its highly anticipated Phase III data to be showcased at the 2025 ...